Pediatric Atopic Dermatitis (AD) Internet Survey

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2011-06-30

Study Completion Date

2014-10-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate whether participation in an Internet-based intervention helps improve atopic dermatitis treatment outcomes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit

NCT00654355

Atopic Dermatitis

COMPLETED PHASE4

Efficacy of Topical Coal Tar in Children With Atopic Dermatitis

NCT03461302

Atopic Dermatitis

UNKNOWN PHASE4

Clinical vs. Anecdotal Evidence - Pediatric Atopic Dermatitis

NCT03559075

Atopic Dermatitis

COMPLETED

Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis

NCT01782703

Atopic Dermatitis Eczema

ACTIVE_NOT_RECRUITING

Atopic Dermatitis (AD) and Food Allergy

NCT03168113

Atopic Dermatitis (AD) Non-atopic Healthy Controls

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atopic Dermatitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

TRIPLE

Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Weekly Internet survey w medication

Weekly survey via email plus topical triamcinolone

Group Type EXPERIMENTAL

Weekly Internet survey

Intervention Type BEHAVIORAL

Parents will complete a weekly online survey about medication use.

Topical Triamcinolone

Intervention Type DRUG

Topical triamcinolone to all affected areas once daily

Topical triamcinolone only

Standard of care

Group Type ACTIVE_COMPARATOR

Topical Triamcinolone

Intervention Type DRUG

Topical triamcinolone to all affected areas once daily

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Weekly Internet survey

Parents will complete a weekly online survey about medication use.

Intervention Type BEHAVIORAL

Topical Triamcinolone

Topical triamcinolone to all affected areas once daily

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Any child age 2 to 8 with a diagnosis of atopic dermatitis confirmed by a dermatologist, together with the child's parent/guardian. Written consent must be given by parent/guardian.

Exclusion Criteria

* Child is less than 2 or greater than 8 years of age.
* Known allergy or sensitivity to topical triamcinolone in the child.
* Inability to complete all study-related visits, or inability to complete the Internet survey due to inadequate Internet access.
* Introduction of any other prescription medication, topical or systemic, for atopic dermatitis while participating in the study. Subjects who are on systemic anti-inflammatory treatments for atopic dermatitis must be on a stable dose for at least 3 months prior to enrollment.

Minimum Eligible Age

2 Years

Maximum Eligible Age

8 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No